Beneficient Enters into $1.36 Million GP Primary Capital Transaction

Published on January 7, 2025

announced it has closed on the financing of a $1.36 million primary capital commitment for 8F Fund, LP (“Fund”), a fund managed by 8F Asset

Continue reading on website
Other news

QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening

January 7, 2025
potential investors to explore strategic partnerships and investment opportunities, including discussions about QUANTRO’s current financing

YieldMax™ ETFs Fortified by Enhanced Trading Capabilities Following Integration of ZEGA and Tidal Teams

January 7, 2025
’s dedication to delivering high-value investment solutions that meet the evolving needs of investors. “This collaboration elevates our